TY  - JOUR
AU  - Sánchez-Rovira, Pedro
AU  - Hirschberg, Angelica Lindén
AU  - Gil-Gil, Miguel
AU  - Bermejo-De Las Heras, Begoña
AU  - Nieto-Magro, Concepción
PY  - 2020
DO  - 10.1634/theoncologist.2020-0417
UR  - http://hdl.handle.net/10668/15643
T2  - The oncologist
AB  - The levels of circulating follicle-stimulating hormone, luteinizing hormone, estriol, estradiol, and estrone remained unchanged after a 12-week treatment with 0.005% estriol vaginal gel in postmenopausal women receiving nonsteroidal aromatase...
LA  - en
KW  - Aromatase Inhibitors
KW  - Breast Neoplasms
KW  - Estradiol
KW  - Estriol
KW  - Estrogens
KW  - Female
KW  - Humans
KW  - Middle Aged
KW  - Postmenopause
KW  - Prospective Studies
KW  - Quality of Life
KW  - Vagina
KW  - Vaginal Creams, Foams, and Jellies
TI  - A Phase II Prospective, Randomized, Double-Blind, Placebo-Controlled and Multicenter Clinical Trial to Assess the Safety of 0.005% Estriol Vaginal Gel in Hormone Receptor-Positive Postmenopausal Women with Early Stage Breast Cancer in Treatment with Aromatase Inhibitor in the Adjuvant Setting.
TY  - research article
VL  - 25
ER  -